Search results for peptide therapeutics are dominated by vendors selling product and med-spa pages selling appointments. PeptideReport.ai is neither — it's an independent, physician-authored reference that grades the evidence honestly, names what's uncertain, and never sells you a compound.
Type almost any peptide compound name into a search engine and the results are dominated by two categories: companies selling the compound, and clinics selling a consultation. Almost nobody is publishing what a physician would actually want to know first — how strong the human evidence really is, what the regulatory status honestly means, and where the marketing has run ahead of the science.
Every compound is rated on a modified Oxford evidence hierarchy (Level I through V) — so "FDA-approved," "Russian Phase III," and "rodent data only" are never presented as equivalent.
No product links, no sourcing recommendations, no affiliate vendor relationships. The only recommended next step is a conversation with a licensed physician.
Every page is authored and reviewed under a named physician's byline — with an explicit methodology page describing how sources are chosen and errors are corrected.
FDA-approved, Russian pharma-approved, and no-jurisdiction-anywhere are three very different things — and this site says which one applies to every compound, every time.
Rather than an alphabetical compound list, PeptideReport.ai organizes research by the biological system a compound acts on — because that's how a physician actually reasons through compound selection.
Plain-language guides for the questions that come before compound selection — legality, safety, finding a qualified prescriber, and what "research compound" actually means.
PeptideReport.ai is an educational research reference. It does not diagnose, prescribe, or sell any compound, and nothing on this site should be interpreted as a recommendation to self-administer a peptide without physician oversight. Content addresses adults 21 and older, states each compound's regulatory status plainly (FDA-approved, foreign-approved, or investigational-only), and avoids disease-cure claims. Every research pathway on this site ends the same way: talk to a licensed physician who can evaluate your specific health history.
Straight answers to what people ask most about PeptideReport.ai itself and how to use it.
PeptideReport.ai is an independent, physician-authored research reference on peptide therapeutics, organized into eight hubs — cognitive, metabolic, longevity, immune, skin & repair, sexual health, GH axis, and recovery. It grades the human evidence behind each compound instead of repeating vendor or med-spa marketing claims, and it does not sell any product. Every hub and compound profile is authored and reviewed under the named byline of Dr. Scott DelBoccio, DMD.
No. PeptideReport.ai is educational research information only — it is not medical advice, a diagnosis, or a prescription recommendation, and it does not instruct readers on how to obtain or self-administer any compound. Every research pathway on the site points back to the same next step: a conversation with a licensed physician who can evaluate your specific health history.
PeptideReport.ai is authored and physician-reviewed by Dr. Scott DelBoccio, DMD, a dental medicine physician and researcher focused on peptide pharmacology and longevity medicine. Every hub and compound profile reflects his independent synthesis of the primary literature, published under his named byline and corrected in the open when new evidence emerges.
Each compound is rated on a modified Oxford evidence hierarchy running from Level I (strong human randomized-trial data) down to Level V (mechanistic or animal-only data), so a well-studied compound is never presented as equivalent to one backed only by preliminary findings. The site also states each compound's regulatory status plainly — FDA-approved, approved in another jurisdiction, or investigational and research-only.
The Personalized Protocol guide helps a reader organize their own health history, goals, and questions about specific compounds into a structured summary to bring to their physician. It is a preparation and education tool, not a diagnosis, dosing instruction, or treatment plan, and it does not replace an in-person physician evaluation.
Peptide legality is not a single yes-or-no answer — it varies by compound and jurisdiction. Some peptides are FDA-approved prescription medications, others are approved in different countries but not in the U.S., and many circulate as research chemicals or through compounding pharmacies with a more uncertain regulatory footing. See our full "Are Peptides Legal?" guide for compound-by-compound status.